Results 101 to 110 of about 40,749 (237)
Misdiagnosis of diabetic ketoacidosis as hyperventilation syndrome. [PDF]
R A R Treasure+3 more
openalex +3 more sources
A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley +1 more source
Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang+4 more
wiley +1 more source
Treatment of diabetic ketoacidosis with continuous infusion of insulin
William J. Oetgen, Alan R. Figelman
openalex +1 more source
Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features
Abstract Type 1 diabetes (T1D) has been historically regarded as a childhood‐onset disease; however, recent epidemiological data indicate that adult‐onset T1D accounts for a substantial proportion of cases worldwide. There is evidence that adult‐onset T1D is associated with the classic T1D triad of elevated genetic risk, the presence of islet‐specific ...
Carmella Evans‐Molina, Richard A. Oram
wiley +1 more source
Diabetic Ketoacidosis in Children - An Experience in a Tertiary Hospital
Bedowra Zabeen+4 more
openalex +2 more sources
Heterogeneity in the management of diabetic ketoacidosis in Australia: a national survey
Abstract Background Diabetic ketoacidosis (DKA) is a hyperglycaemic emergency, and insulin administration is highly protocolised with either variable‐ or fixed‐rate intravenous infusions. There are limited data supporting superiority of one regimen over another; however, international guidelines recommend fixed‐rate infusions.
Lisa M. Raven+6 more
wiley +1 more source
Editorial: COVID-19 and diabetes, volume II
Hamad Ali+3 more
doaj +1 more source